This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires | MicrobiomeTrials
← Back to trials NCT05567198
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires Recruiting OBSERVATIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2023-03-03Est. Completion: 2027-05-31
Enrollment target: 100 participantsLocations National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, Maryland, United States Other microbiome trials you might be interested in Relapsed/Refractory Autoimmune Diseases
This is a prospective, single-arm, open-label and dose-escalation Investigator Initialed study to evaluate LUCAR-G79 in …
Bengbu, China Completed Mar 20, 2026
Lupus or SLE Spondyloarthritis
Scurvy is an almost forgotten carential pathology, caused by a deep vitamin C (or ascorbic acid) deficiency, a priori ex…
Nice, France Completed Dec 8, 2025